comprehensive -WSS

comprehensive

author：Wikipedia 2025-09-06 04:40:38 - browse：79621

A person picking up medication at a drive through pharmacy window – biotech and pharma coverage from STAT — Adobe

On Tuesday morning, the Department of Health and Human Services unveiled its long-awaited list of the 10 medicines that will be subject to price negotiation in 2026 under the Inflation Reduction Act.

This will mark the first time that Medicare, the government program for paying for health care for older Americans, will have any ability to use its vast size to negotiate for lower prices. It’s not yet clear how big the discounts on these 10 drugs will be, or even if the law will hold up to multiple legal challenges from the pharmaceutical industry. It’s also not clear, as critics from the drug industry have noted, whether any savings to the government will be passed on to consumers.

Still, the naming of 10 medicines is a milestone, and a point to start appraising the impact of the law. The landscape here is complicated. No one really knows how the IRA’s price negotiation process will play out over the short and long term, and many companies who had products named were spared in other ways, with products many industry watchers expected to see on the list absent. Here is STAT’s assessment of who has won and lost.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Pfizer, Moderna say biotech, pharma drug development is a sprint

Wikipedia

WSS

'Patient friction coefficient' can gauge a clinical trial's patient burden

Novavax promises a turnaround & Lilly roils the obesity market

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Drug repurposing or repositioning? The language matters

'Patient friction coefficient' can gauge a clinical trial's patient burden

Alkermes shareholders re

entertainment

comprehensive

entertainment

At least 13 dead in Texas as scorching temps continue

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

Jerome Adams on the need for new antivirals for Covid

Psychedelics group wrestles with new pharma identity

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Chinese researcher claims birth of first gene

Hollywood unions extend contract negotiations for actors

Medical devices makers are asking for forgiveness, not permission

As demand for Covid shots wanes, Moderna seeks its next success

Diabetes management: Digital health tools fall short, study says

leisure time

After affirmative action ruling, medical educators look to 'holistic review'

Erich Jarvis studies song birds to learn about human stuttering

State Dept. review finds Biden bears some blame for Afghanistan failures

Affirmative action in medical school literally saved lives

Surgeons perform first xenotransplant using CRISPR'd pig kidney

Walensky prepares to leave CDC — and Congress — behind

Wikipedia

Wikipedia

leisure time

leisure time